The COVID-19 Rapid Antigen Test Kit is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in nasopharyngeal swab, nasal swab and oropharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider .
This report contains market size and forecasts of COVID-19 Rapid Antigen Test Kits in global, including the following market information:
Global COVID-19 Rapid Antigen Test Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global COVID-19 Rapid Antigen Test Kits Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five COVID-19 Rapid Antigen Test Kits companies in 2021 (%)
The global COVID-19 Rapid Antigen Test Kits market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nasopharyngeal Swab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of COVID-19 Rapid Antigen Test Kits include Abbott, AESKU.GROUP, ARISTA® Biotech, IHealth, Quidel, ACCESS BIO, ROCHE DIAGNOSTICS, Artron Laboratories and Philosys, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Rapid Antigen Test Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Rapid Antigen Test Kits Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Rapid Antigen Test Kits Market Segment Percentages, by Type, 2021 (%)
Nasopharyngeal Swab
Nasal Swab
Oropharyngeal Swab
Saliva Swab
Global COVID-19 Rapid Antigen Test Kits Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Rapid Antigen Test Kits Market Segment Percentages, by Application, 2021 (%)
Hospital
Company
School
Home
Others
Global COVID-19 Rapid Antigen Test Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Rapid Antigen Test Kits Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COVID-19 Rapid Antigen Test Kits revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies COVID-19 Rapid Antigen Test Kits revenues share in global market, 2021 (%)
Key companies COVID-19 Rapid Antigen Test Kits sales in global market, 2017-2022 (Estimated), (K Units)
Key companies COVID-19 Rapid Antigen Test Kits sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
AESKU.GROUP
ARISTA® Biotech
IHealth
Quidel
ACCESS BIO
ROCHE DIAGNOSTICS
Artron Laboratories
Philosys
Innovation Scientific
CTK Biotech
GenBody Inc
SD Biosensor
JOYSBIO
Medriva
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)